Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eisai's Thyroid Cancer Drug Gets FDA Priority Review
Eisai's Thyroid Cancer Drug Gets FDA Priority Review
Eisai's Thyroid Cancer Drug Gets FDA Priority Review
Submitted by
admin
on October 16, 2014 - 9:13am
Source:
Drug Discovery and Development
News Tags:
Eisai
thyroid cancer
FDA
Lenvatinib
Headline:
Eisai's Thyroid Cancer Drug Gets FDA Priority Review
Do Not Allow Advertisers to Use My Personal information
